BioSpace News Archive

The global cell signaling market size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period.

According to Nova one advisor, the global Isothermal Nucleic Acid Amplification Technology market was valued at USD 4.98 billion in 2022 and it is expected to hit around USD 11.9 billion by 2030 with a CAGR of 13.4% during the forecast period 2022 to 2030.

The global In Vitro Diagnostics market size was estimated at USD 111.68 billion in 2021 and is expected to surpass around USD 113.45 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 0.3% during the forecast period 2022 to 2030.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce it has filed a PCT (Patent Cooperation Treaty) application number PCT/IB2022/06117 on November 18, 2022, entitled “Peptides and Uses Thereof”, with the aim of seeking protection for certain peptides comprising D-amino acids and their use in methods of treating brain cancer.

The global optogenetics market size reached a significantly robust value in 2020 and is expected to register a notable CAGR over the forecast period.

Digital biology involves studying the fundamental computation of various biological processes, including gene regulatory systems and neural networks.

180 Life Sciences Corp. today announced that the Company will participate in A.G.P.’s Virtual Biotech Conference to be held November 30 – December 1, 2022.

Schrödinger today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference.

Ainos, Inc. announced that it has published preclinical data demonstrating the potential of its low-dose oral interferon-alpha formulation, VELDONA®, as treatment candidates for the two most common medical conditions for dogs and cats.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock in an underwritten public offering.